Cargando…

Identification and validation of novel biomarker TRIM8 related to cervical cancer

BACKGROUND: Cervical cancer, as a common gynecological disease, endangers female health. Give the lack of effective biomarkers for the diagnosis and treatment of cervical cancer, this paper aims to analyze the Gene Expression Omnibus (GEO) data sets using comprehensive bioinformatics tools, and to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Dan, Youli, Ou, Chaoyang, Qian, Hongyan, Yin, Yi, Tang, Min, He, Qian, Peng, Chen, He, Aiqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638460/ https://www.ncbi.nlm.nih.gov/pubmed/36353542 http://dx.doi.org/10.3389/fonc.2022.1002040

Ejemplares similares

The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer
por: Zhang, Can, et al.
Publicado: (2019)

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
por: Ren, Wenjun, et al.
Publicado: (2022)

TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis
por: Wang, Xiao-Yu, et al.
Publicado: (2022)

Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics
por: Zhang, Zhenhua, et al.
Publicado: (2022)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

CRTC2 promotes paclitaxel resistance by inducing autophagy in ovarian cancer in part via the PI3K-AKT signaling axis
por: Ou, Chaoyang, et al.
Publicado: (2023)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis
por: Jiang, Jie, et al.
Publicado: (2021)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Identification of CD8+ T cell infiltration-related genes and their prognostic values in cervical cancer
por: Shen, Xiaopeng, et al.
Publicado: (2022)

Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

SNHG8 Promotes the Progression of Epstein–Barr Virus-Associated Gastric Cancer via Sponging miR-512-5p and Targeting TRIM28
por: Zou, Changyan, et al.
Publicado: (2021)

Up-Regulation of TRIM32 Associated With the Poor Prognosis of Acute Myeloid Leukemia by Integrated Bioinformatics Analysis With External Validation
por: Xu, Xiaoyan, et al.
Publicado: (2022)

New Paradigm of Machine Learning (ML) in Personalized Oncology: Data Trimming for Squeezing More Biomarkers From Clinical Datasets
por: Borisov, Nicolas, et al.
Publicado: (2019)

Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation
por: Geier, Brian, et al.
Publicado: (2015)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)

TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background
por: Caratozzolo, Mariano Francesco, et al.
Publicado: (2019)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

High expression of PYK2 is associated with poor prognosis and cancer progression in early-stage cervical carcinoma
por: Zhang, Can, et al.
Publicado: (2022)

TRIM31: A molecule with a dual role in cancer
por: Guo, Yafei, et al.
Publicado: (2022)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Li, Shuai, et al.
Publicado: (2021)

Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma
por: Du, Minjun, et al.
Publicado: (2021)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling
por: Chai, Yanlan, et al.
Publicado: (2015)

Identification and validation of immune-related hub genes based on machine learning in prostate cancer and AOX1 is an oxidative stress-related biomarker
por: Mo, Xiaocong, et al.
Publicado: (2023)

Identification and Validation of Stage-Associated PBMC Biomarkers in Breast Cancer Using MS-Based Proteomics
por: Moradpoor, Raheleh, et al.
Publicado: (2020)

Hexokinase 2 Promotes Cell Growth and Tumor Formation Through the Raf/MEK/ERK Signaling Pathway in Cervical Cancer
por: Cui, Nan, et al.
Publicado: (2020)

Preoperative Evaluation of Perineural Invasion in Cervical Cancer: Development and Independent Validation of a Novel Predictive Nomogram
por: Wan, Ting, et al.
Publicado: (2021)

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma
por: Sun, Xu, et al.
Publicado: (2023)

Identification of TRIM56 as a Potential Biomarker for Lung Adenocarcinoma
por: Lu, Kun, et al.
Publicado: (2021)

Predictive value of indicator of CA125 combined with D-dimer (ICD) for lymph node metastasis in patients with ovarian cancer: A two center cohort study
por: Zhang, Li, et al.
Publicado: (2022)

Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in Prostate Cancer
por: Li, Chao, et al.
Publicado: (2022)

Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer
por: Liu, Chuanyang, et al.
Publicado: (2019)

Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma
por: Zhao, Sufeng, et al.
Publicado: (2022)

Linc00963 Promote Cell Proliferation and Tumor Growth in Castration-Resistant Prostate Cancer by Modulating miR-655/TRIM24 Axis
por: Bai, Minghua, et al.
Publicado: (2021)

Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis
por: Wu, Xuan, et al.
Publicado: (2019)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
por: Zhang, Cuijian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6af5oiaas1mdnvlli9gm48i4m